TipRanks on MSN
HeartBeam (NASDAQ: BEAT) Reports Q3 2025 Results as FDA Review Nears Completion and Commercial Readiness Accelerates
Austin, Texas, United States, November 14th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT) reported third-quarter 2025 results ...
The rhythm is regular at a rate of 95 beats/min. The QRS complex has a normal duration (0.08 sec) and morphology, with an axis between 0° and +90° (positive QRS complex in leads I and aVF). There is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results